REPORT SCOPE
INTRODUCTION
STUDY GOALS AND OBJECTIVES
BCC’s primary goal in conducting this study was to explore the different factors affecting the industries involved with gastrointestinal endoscopy equipment. Growth in this field is affected by many factors, including an aging global population and an increase in the number of gastrointestinal conditions and treatments (e.g., colon and rectal cancer treatments, obesity treatments, the use of gastric banding as an aid for weight loss for the morbidly obese). Also, revolutionary technology evolution is allowing less-invasive and more real-time diagnosis of gastrointestinal problems.
There are many different and complex analytical technologies involved, as well as many different types of gastrointestinal endoscopy equipment, depending on the sophistication of the medical facility performing the treatment. Thus, it is imperative that the stakeholders in the innovation, manufacture, and production of endoscopy equipment; medical practitioners and facilities performing related treatments; and investors in the more generalized medical and surgical field understand the economic growth factors for this field within a volatile economy.
REASONS FOR DOING THE STUDY
With a globally aging population and new standards for preventative diagnostic screening required by many insurance organizations (obesity is now recognized as a disability, which leads to more treatments for morbidly obese patients recognized and covered by even conventional medical insurance companies), this study will show the overall landscape of gastrointestinal endoscopy equipment.
Additionally, it will identify many different companies offering innovative and more conventional equipment relating to gastrointestinal endoscopy, including current and forecasted revenues, as well as targeted population disease and condition statistics as they are available.
SCOPE OF REPORT
The scope of this study encompasses several different specific technology- and procedure-based areas relating directly to gastrointestinal endoscopy. It primarily focuses on those industry stakeholders providing advanced technological solutions for human conditions, but it also includes a smaller, less-granulated analysis of comparable products offered to the veterinary use of gastrointestinal endoscopy on its patient population.
BCC analyzed the industry on a worldwide basis from the market, product, and technology perspectives. Regulations in the U.S. and global markets were also examined to identify consumer safety, product introduction and product safety regulatory issues for stakeholders and potential stakeholders in this industry.
Consideration has been given for the changing economy, and all statistical reporting and forecasting takes into account current trends and other available data indicating company, product, and application stability or instability. Clearly, not every factor can be taken into account, particularly because companies with no indication of financial instability have gone almost instantly from near giants in their field to bankruptcy and dissolution. In reality, close scrutiny of financial reporting should reveal many such trends, however, there are increasing indications that either through inefficient or positively deceptive accounting and fiscal reporting, or through mismanagement, a remarkably large number of these companies have stated that they have been genuinely been unaware of their pending status changes.
METHODOLOGY
BCC presents an analysis across the entire gastrointestinal endoscopy equipment market based on revenue dollars and units shipped as reported to the SEC and/or other governmental agencies. We also analyzed data gathered from various research sources via the Internet, including the United States Patent Office (USPTO) database, the U.S. Patents and Patent Applications database, Micropatent’s searchable databases for U.S. and international patents and other IP issues, and the European Patent Office for World and U.S. Patents and Patent Applications searchable database.
INTENDED AUDIENCE
Gastrointestinal endoscopy is a field driven by rapidly evolving technology, a globally aging population, and the increased recognition of many problems associated with morbid obesity that can sometimes be addressed by relatively noninvasive or minimally invasive placement of gastric banding. Stakeholders within the gastrointestinal endoscopy industry, as well as medical providers and facilities, can benefit greatly by gaining an understanding of the available equipment and technologies according to the qualifications and sophistication of their medical and surgical facilities. Medical providers can benefit from the availability of cumulative information, particularly those medical administrators making equipment purchasing decisions for their gastrointestinal surgical departments or clinics.
Market segment financial numbers are based on real reported revenue and primary investigation, and interviews and conventional statistical estimation and forecasting algorithms and techniques are used to report financial trending.
In the current economy, it must be mentioned that even regarding companies listed within this report as being well-positioned, well-funded, and with current and pending technology to serve the increasing needs for gastrointestinal endoscopy equipment, investors or potential consumer companies should meticulously examine provider or vendor companies before making tangible business decisions. For many companies, this economy marks enormous negative change, but for others that were well-ahead of their product life-cycle, new and exciting products and technologies within this field continue to be introduced into the gastrointestinal endoscopy equipment market.
INFORMATION SOURCES
BCC interviewed primary sources from many different identified organizational stakeholder companies in the gastrointestinal endoscopy equipment and supply industry and analyzed public documents, SEC filings, corporate white papers, and other technical documentation for several dozen U.S. and international companies directly involved in manufacturing and distributing of gastrointestinal endoscopy equipment.
Additionally, BCC analyzed more than 1,100 design and utility patents filed in the U.S. and throughout the world on gastrointestinal endoscopy-related inventions, reducing the number to 559 patents directly relevant to the subject matter of this market research report.
ANALYST CREDENTIALS
Jordan Sheridan is a technology analyst and writer with more than 20 years of experience who has specialized in technology and intellectual property strategies, and has developed IP documentation and analysis studies for Fortune 100 companies, with particular emphasis on IT technology and algorithmically-based inventions. Sheridan’s publications for BCC Research include RFID: Technology, Applications, and Market Potential (IAS020A); The Global Market for Energy Management Information Systems (EGY052A); Technologies for Air Pollution Monitoring, Prevention, and Control (IAS001G); Artificial Sensing: Technologies and Emerging Markets (IAS021A); Advanced Materials for Sensors (AVM058A); Active, Controlled, and Intelligence Packaging for Foods and Beverages (FOD038B); Emergency Response Technologies: Global Markets (SAS014A); Process Spectroscopy Market and Technology Update (IAS008C); Entertainment Technology Market Dynamics and Technology Innovations (IFT067A); Home Theater Technologies and Services: The Global Market (IFT069A); and Portable Analysis Instrumentation: The Global Market (IAS028A).
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
